CIK 0000715446 · Non-accelerated filer<br>Smaller reporting company
Anixa Biosciences Inc
Sign in to watch- Ticker
- ANIX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Oct 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 112622630
- Phone
- 408-708-9808
- Business address
- 3150 ALMADEN EXPRESSWAY, SUITE 250, SAN JOSE, CA, 95118
- Former names
- ITUS Corp, COPYTELE INC
- Open-market buys, last 90 days
- $291,587
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$291,587. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-10-29 | Titterton Lewis H jr Director | Purchase | +18,244 | $4.76 | $87K | 954,070 |
| 2021-10-29 | KUMAR AMIT Chief Executive Officer | Purchase | +2,000 | $4.77 | $10K | 294,000 |
| 2021-07-26 | Titterton Lewis H jr Director | Purchase | +30,000 | $4.21 | $126K | 935,826 |
| 2021-07-23 | KUMAR AMIT Chief Executive Officer | Purchase | +5,000 | $4.28 | $21K | 292,000 |
| 2021-07-23 | Baskies Arnold M Director | Purchase | +19,000 | $4.33 | $82K | 100,000 |
| 2021-07-16 | KUMAR AMIT Chief Executive Officer | Purchase | +10,000 | $3.94 | $39K | 287,000 |
| 2021-07-16 | Titterton Lewis H jr Director | Purchase | +10,000 | $4.07 | $41K | 905,826 |
| 2021-07-15 | Titterton Lewis H jr Director | Purchase | +2,200 | $3.65 | $8K | 895,826 |
| 2021-07-15 | Gottschalk Emily Director | Purchase | +20,065 | $3.96 | $79K | 45,665 |
| 2021-07-15 | Baskies Arnold M Director | Purchase | +20,000 | $3.90 | $78K | 81,000 |
| 2021-07-14 | Titterton Lewis H jr Director | Purchase | +23,300 | $3.72 | $87K | 893,626 |
| 2021-06-01 | Baskies Arnold M Director | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-06-01 | Titterton Lewis H jr Director | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-06-01 | Titterton Lewis H jr Director | Grant or award · Employee Stock Option (Right to Buy) | +200,000 | 200,000 | ||
| 2021-06-01 | Gottschalk Emily Director | Grant or award · Employee Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2021-06-01 | Catelani Michael COO & CFO | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-06-01 | Catelani Michael COO & CFO | Grant or award · Employee Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2021-06-01 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +2,000,000 | 2,000,000 | ||
| 2021-06-01 | KUMAR AMIT Chief Executive Officer | Grant or award · Employee Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2021-05-31 | KUMAR AMIT Chief Executive Officer | Returned to the company · Restricted Stock Award | −1,500,000 | 0 |
Page 7 of 21 · 404 trades